Signal activated phospholipases are a recent focus of the rapidly growing field of lipid signaling. The extent of their impact on the pathways regulating diverse cell functions is beginning to be appreciated. A critical step in inflammation is the attraction of leukocytes to injured or diseased tissue. Chemotaxis of leukocytes, a requisite process for monocyte and neutrophil extravasation from the blood into tissues, is a critical step for initiating and 
Much of what we know about signal transduction pathways that regulate eukaryotic cell chemotaxis has been determined from studies in the Dictyostelium slime mold model system. Some signaling pathways shown to regulate chemotaxis are shared between Dictyostelium and leukocytes, while others are not. In most cases, pathways have first been identified to play a role in Dictyostelium and then further explored in leukocytes for their relevance. An exception to this is the recently identified role that PLA 2 have in regulating the speed of migration and the directionality of leukocyte chemotaxis. Both cPLA 2 and iPLA 2 , the intracellular signal activated PLA 2 , were first discovered to regulate chemotaxis in leukocytes (1, 2). The homolog of iPLA 2 was later shown to regulate chemotaxis in Dictyostelium, whereas cPLA 2 does not seem to have a counterpart in this organism (3, 4) . Recent studies in Dictyostelium have revealed a complex by guest, on August 15, 2017 www.jlr.org Downloaded from set of parallel pathways that play lesser or greater roles in regulating chemotaxis depending on the steepness of the chemokine gradient as well as the developmental stage of this organism [(3, 4) and reviews (5, 6) ]. Therefore it is critical to examine the relevance of particular pathways anew in leukocytes prior to presuming their participation in the chemotactic response.
MCP-1 (also known as CCL2) is an example of a chemotactic factor that is important in both acute and chronic inflammatory responses. In vivo studies have revealed that it is predominantly a chemokine for attracting monocytes. Despite in vitro reports of other chemokines with the capacity to attract monocytes, studies in MCP-1-deficient mice have revealed that MCP-1 is solely responsible for monocyte recruitment in a variety of inflammatory settings (7) . Furthermore, MCP-1 expression has been documented in disorders characterized by mononuclear cell infiltrates, suggesting that it contributes to the inflammatory component of such diseases as atherosclerosis, allergy, multiple sclerosis, or rheumatoid arthritis (8, 9) .
Although MCP-1 is believed to be important in these disease processes, until recently relatively little was known about how MCP-1 signals through its receptor, CCR2, to induce monocyte chemotaxis. This defined chemokine-induced chemotactic response for primary human monocytes serves as a relevant model system for identifying lipid regulatory pathways, assessing their relevance in vivo and designing future therapies for targeting these novel pathways for anti-inflammatory treatments. This review will summarize our current understanding of how signal activated phospholipases and their products regulate eukaryotic cell migration in general and specifically focus on chemotaxis of primary human monocytes to MCP-1. The in vitro versus in vivo roles for these signal activated phospholipases will be discussed as well as their potential to serve as targets for controlling inflammatory responses.
Phospholipases A 2
by guest, on August 15, 2017 www.jlr.org
Downloaded from
Phospholipase A 2 (PLA 2 ) enzymes hydrolyze the fatty acyl group from the sn-2 position of glycerophospholipids resulting in the generation of free fatty acid (e.g. arachidonic acid, AA) and lysophospholipid, e.g. lysophosphatidyl choline). Leukocytes have three different broad classes of PLA 2 : 1) secretory, referred to as sPLA 2 (Groups II and X); 2) calcium-dependent cytosolic phospholipase A 2 (cPLA 2 , Group IV); and 3) calcium-independent phospholipase A 2 (iPLA 2 , Group VI). Only two of these are intracellular signal transducing, signal activated phospholipases, cPLA 2 and iPLA 2 . In this section, the focus will we be on the two intracellular, signal activated PLA 2 , cPLA 2 and iPLA 2 and specifically cPLA 2 α and iPLA 2 β. Activity of these phospholipases can be inhibited by a variety of pharmacologic inhibitors and antisense oligodeoxyribonucleotides have been designed that specifically block the expression of cPLA 2 and iPLA 2 (1, 10).
A. cPLA 2 regulation of chemotaxis cPLA 2 is an intracellular, 110 kDa enzyme that requires nanomolar to micromolar concentrations of calcium to become activated. It is the only identified PLA 2 that selectively cleaves sn-2 arachidonic acid (AA), and therefore significantly contributes to agonist-induced AA release and the formation of potent AA metabolites (11) . cPLA 2 activity is induced by protein phosphorylation and calcium-dependent translocation to membranes from the cytosol (12) . Protein kinase C (PKC) has been shown to regulate cPLA 2 phosphorylation and activity in activated human monocytes (13) (14) (15) ).
An important role for cPLA 2 in regulating monocyte chemotaxis was first reported by are not required pathways for monocytes to chemotactically respond to MCP-1 since neither of these drugs affected chemotaxis (Cathcart, M.K. et al, unpublished data). Therefore, the current focus of these studies is on the potential contributions of the products formed by the cytochrome p450 enzyme pathway. Important roles for Cyp products and soluble epoxide hydrolase in inflammatory processes have been defined through the use of several urea based inhibitors (17) . This general role in inflammation may be related to the role that Cyp products are playing in leukocyte chemotaxis.
Little is known about the Cyp enzymes or their products and cell migration. This is primarily due to the recently identified fact that Cyp enzymes are remarkably labile in cell culture and most cell lines have lost expression of this enzyme family. As a result, this pathway merits a closer look for its role in regulating chemotaxis since the technical limitations of prior studies resulted in underestimating the potential impact of the epoxyeicosatetraeonic acids (EET) products of these enzymes in biologic responses and since EETs have been shown to promote cell migration in certain systems (18) . Arachidonic acid and EETs have been reported to cause increases in intracellular calcium through both store-operated calcium channels and calcium influx (19) (20) (21) (22) (23) . The location of cPLA 2 in the endoplasmic reticulum is consistent with a possible role of Cyp products in regulating localized calcium release from intracellular stores. Calcium increases could certainly affect events critical for monocyte migration.
It is also possible that AA itself, and not a metabolite, is the regulator of cPLA 2 -dependent chemotaxis and based on prior work, one cannot ignore the fact that AA may regulate chemotaxis by modulating the production of reactive oxygen species, since cPLA 2 -generated AA is essential in regulating the production of O 2
. by activated human monocytes via NADPH oxidase as well as regulating intracellular calcium levels (10, 14, 15 calcium levels and the activation of calcium-dependent enzymes, e.g. cPLA 2 and protein kinase C. Diacylglycerol also serves as a substrate for DAG kinases and is a potent activator of certain PKC isoforms. Each of these pathways can regulate the processes of cell motility.
Studies in Dictyostelium suggest that PLC regulates the PI3K-mediated chemotaxis pathway and F-actin polymerization at the leading edge [reviewed in (24) ]. In leukocytes the role for PLC in regulating chemotaxis is rather confusing with evidence supporting a role in some chemotactic factor-induced biologic responses such as superoxide anion production and calcium signaling while not influencing chemotaxis. In Dictyostelium PLC has been reported to regulate the localization of the phosphatase and tensin homolog PTEN and actually inhibit chemotaxis to cyclic AMP (33) . The role for PLC may ultimately prove to be both cell type and chemotactic factor dependent. The contributions of PLC to leukocyte chemotaxis deserves further study.
The action of PLD on its substrate phosphatidylcholine (or other glycerophospholipids) results in the formation of phosphatidic acid (PA) and choline (or other head group) as a result of an attack on the phosphodiester bond. Among the phospholipases, relative little is understood about how PLD contributes to leukocyte chemotaxis. Studies on neutrophils responding to the formyl peptide (formylMetLeuPhe) suggest that PLD activity may regulate inside-out activation of the β2 integrin, CD11b/CD18 that is important for influencing leukocyte adhesion and migration (34, 35 ). This appears to be due to PA regulation of the generation of PtdIns(4,5)P 2 and promotion of talin binding to the cytosolic domain of CD18. When PLD activity was blocked, PA restored migration. Other investigators did not see this same effect of PLD on formylMetLeuPhe-induced neutrophil chemotaxis and the reasons for this discrepancy are not clear at this time but may be related to the very different chemotaxis assays employed in these two studies (36) .
Recent studies in our lab indicate that MCP-1 induces rapid activation of PLD and that pharmacologic inhibition of PLD results in inhibition of PLD activity in concert with inhibition of monocyte chemotaxis to MCP-1. When PLD activity was inhibited monocyte chemotaxis to MCP-1 was restored when PA was added to the monocytes (Cathcart, M.K. et al, unpublished data). Since PLD-derived PA can serve as a substrate for subsequent iPLA 2 cleavage generating LPA and free fatty acid, we surmise that PLD activity is an upstream requirement for providing PA as a substrate for iPLA 2 , thereby regulating monocyte chemtotaxis via the iPLA 2 pathway discussed earlier in this review (Figure 1 ).
In Vivo Validation
It does not necessarily follow that a dependence of monocyte chemotaxis on a signal activated phospholipase activity in vitro implies that this also happens in vivo. There are many reasons, not the least of which is the complexity of the in vivo system, that in vitro findings may prove invalid in vivo. It is therefore necessary to validate the significance of these pathways in vivo in inflammatory responses. For studies characterizing pathways that regulate MCP-1-dependent chemotaxis it is fortuitous that thioglycollate-induced monocyte peritoniteal inflammation in mice has been shown to be dependent on MCP-1. This model was used to test the relevance of both iPLA 2 and cPLA 2 for regulating inflammation in vivo by conducting adoptive transfer of monocytes rendered deficient in iPLA 2 or cPLA 2 (16) . These studies indicated that both phospholipases are indeed critical for in vivo monocyte chemotaxis and thereby suggest that these pathways may serve as opportune targets for intervention in the process of inflammation. The adoptive transfer model system was performed using tagged mouse monocytes transferred to recipient animals. This model has also been used to monitor the trafficking of human monocytes in mice during peritonitis and human monocytes were shown to traffic similarly to mouse monocytes (37) . Therefore this adoptive transfer model can be used to assess the relevance of a particular enzyme for regulating human monocyte chemotaxis. Similar studies are necessary for validating other pathways for in vivo relevance.
Future therapeutic approaches
Although the much of what we know about the roles for signal activated phospholipases in human cells is derived from lipid regulation of monocyte and neutrophil chemotaxis, the relevance of these findings implicating critical roles for signal activated phospholipases to cell migration in general remains to be elucidated. Data suggest that signal activated phospholipases contribute to chemotaxis of many cell types, including monocytes, vascular smooth muscle cells, endothelial cells and neutrophils (Cathcart, M.K. et al, unpublished data).
The requirement for signal activated phospholipases and their lipid products in controlling leukocyte chemotaxis makes them a logical target for therapeutic intervention. The possibility that these enzymes may be involved in regulating general cell movement in a more global sense would limit the value of targeting these pathways for controlling leukocyte recruitment. In this case it would be critical to target this intervention specifically to monocyte/macrophages and/or neutrophils.
Conclusions
Signal activated phospholipases play critical roles in regulating the chemotactic response, particularly in leukocytes. The exact mechanisms that are controlled by these phospholipases remain to be fully elucidated and merit future study. The information gleaned from this research will advance our understanding of the mechanisms that control this important biological event and will suggest novel therapeutic approaches for treatment of inflammatory diseases.
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